We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Imaging Agent Could Help Measure Effectiveness of Breast Cancer Therapy Earlier

News   Feb 12, 2019 | Original story from the Society of Nuclear Medicine and Molecular Imaging

 
Imaging Agent Could Help Measure Effectiveness of Breast Cancer Therapy Earlier

Representative coronal 18F-FFNP PET/CT images of MDA-MB-231 (red arrow), 231 PR-A (white arrows), and 231 PR-B (yellow arrow) tumor xenografts (19 d after implantation) from 12 mice imaged 1 h after injection with 10 MBq (270 μCi) of 18F-FFNP. Physiologic uptake from hepatobiliary clearance is also visualized. Credit: K Salem et al., University of Wisconsin School of Medicine and Public Health, Madison, WI

 
 
 

RELATED ARTICLES

Blood Gene Expression Markers Predictive of Pain

News

A breakthrough test to measure pain in patients could help stem the tide of the opioid crisis in Indiana, and throughout the rest of the nation.

READ MORE

Reversing Memory Loss Linked to Depression and Aging

News

New therapeutic molecules developed at Toronto’s Centre for Addiction and Mental Health (CAMH) show promise in reversing the memory loss linked to depression and aging.

READ MORE

Link Between Common Weedkiller and Some Cancers

News

Exposure to glyphosate — the world’s most widely used, broad-spectrum herbicide and the primary ingredient in the weedkiller Roundup — increases the risk of some cancers by more than 40 percent, according to new research.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE